Nanotechnology for neurodegenerative disorders

Maturitas

Volumn 73, Issue 1, 2012, Pages 45-51

  Re, Francesca ^a   Gregori, Maria ^a   Masserini, Massimo ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Blood brain barrier; Brain; Nanomaterials; Nanoparticles; Neurodegenerative disorders

Indexed keywords

NANOMATERIAL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; HUMAN; NANOTECHNOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; REVIEW; TISSUE REGENERATION; TRANSCYTOSIS;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOOD-BRAIN BARRIER; DRUG CARRIERS; HUMANS; NANOMEDICINE; NANOPARTICLES; NERVE REGENERATION; PARKINSON DISEASE; PRION DISEASES;

EID: 84864968964     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.12.015     Document Type: Review

References (54)

1. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol Dis 37 2010 48 57
2. C. Fernandes, U. Soni, and V. Patravale Nano-interventions for neurodegenerative disorders Pharmacol Res 62 2010 166 178
3. N.J. Abbott, D.C. Chugani, G. Zaharchuk, B.R. Rosen, and E.H. Lo Delivery of imaging agents into brain Adv Drug Deliv Rev 37 1999 253 277 (Pubitemid 29164512)
4. M.M. Patel, B.R. Goyal, S.V. Bhadada, J.S. Bhatt, and A.F. Amin Getting into the brain: approaches to enhance brain drug delivery CNS Drugs 23 2009 35 58
5. S. Bhaskar, F. Tian, and T. Stoeger Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging Part Fibre Toxicol 7 2010 3
6. H.R. Kim, K. Andrieux, and S. Gil Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis Biomacromolecules 8 2007 793 799 (Pubitemid 46488459)
7. K. Ulbrich, T. Hekmatara, E. Herbert, and J. Kreuter Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur J Pharm Biopharm 71 2009 251 256
8. R.J. Boado A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery Drug News Perspect 21 2008 489 503
9. L.M. Ittner, and J. Götz Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease Nat Rev Neurosci 12 2011 65 72
10. Y. Matsuoka, M. Saito, and J. LaFrancois Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid J Neurosci 23 2003 29 33 (Pubitemid 36050401)
11. M. Gobbi, F. Re, and M. Canovi Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide Biomaterials 31 2010 6519 6529
12. E. Bereczki, F. Re, M.E. Masserini, B. Winblad, and J.J. Pei Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells Nanomedicine 7 2011 560 571
13. M. Canovi, E. Markoutsa, and A.N. Lazar The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue Biomaterials 32 2011 5489 5497
14. S. Mourtas, M. Canovi, and C. Zona Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide Biomaterials 32 2011 1635 1645
15. M. Taylor, S. Moore, and S. Mourtas Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide Nanomedicine 7 2011 541 550
16. I.Y. Podolski, Z.A. Podlubnaya, and E.A. Kosenko Effects of hydrated forms of C60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task J Nanosci Nanotechnol 7 2007 1479 1485
17. G. Liu, P. Men, G. Perry, and M.A. Smith Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease Prog Brain Res 180 2009 97 108
18. G. Liu, P. Men, W. Kudo, G. Perry, and M.A. Smith Nanoparticle-chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease Neurosci Lett 455 2009 187 190
19. B. Wilson, M.K. Samanta, K. Santhi, K.P. Kumar, N. Paramakrishnan, and B. Suresh Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles Eur J Pharm Biopharm 70 2008 75 84
20. D.G. Georganopoulou, L. Chang, and J.M. Nam Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease Proc Natl Acad Sci USA 102 2005 2273 2276 (Pubitemid 40279365)
21. A. Neely, C. Perry, and B. Varisli Ultrasensitive and highly selective detection of Alzheimer's disease biomarker using two-photon Rayleigh scattering properties of Au nanoparticle ACS Nano 3 2009 2834 2840
22. M. Kosicek, S. Kirsch, and R. Bene Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients - a pilot study Anal Bioanal Chem 398 2010 2929 2937
23. L. Feng, S. Li, B. Xiao, S. Chen, R. Liu, and Y. Zhang Fluorescence imaging of APP in Alzheimer's disease with quantum dot or Cy3: a comparative study J Cent South Univ 35 2010 903 909
24. J. Yang, Y.Z. Wadghiri, and D.M. Hoang Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging Neuroimage 55 2011 1600 1609
25. C.A. Roney, V. Arora, P.V. Kulkarni, P.P. Antich, and F.J. Bonte Nanoparticulate radiolabelled quinolines detect amyloid plaques in mouse models of Alzheimer's disease Int J Alzheimer Dis 2009 2010 481031
26. N.B. Cole, and D.D. Murphy The cell biology of alpha-synuclein: a sticky problem? Neuromol Med 1 2002 95 109 (Pubitemid 37012519)
27. G. Modi, V. Pillay, and E. Yahya Choonara Advances in the treatment of neurodegenerative disorders employing nanotechnology Ann NY Acad Sci 1184 2010 154 172
28. A. Trapani, E. De Giglio, and D. Cafagna Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery Int J Pharm 419 2011 296 307
29. R. Huang, W. Ke, and Y. Liu Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model J Neurol Sci 290 2010 123 130
30. 2 nanotube arrays for the detection of α-synuclein Chemistry 16 2010 14439 14446
31. J. Yu, and Y.L. Lyubchenko Early stages for Parkinson's development: alpha-synuclein misfolding and aggregation J Neuroimmune Pharmacol 4 2009 10 16
32. R. Baron, M. Zayats, and I. Willner Dopamine-, L-DOPA-, adrenaline-, and noradrenaline-induced growth of Au nanoparticles: assays for the detection of neurotransmitters and of tyrosinase activity Anal Chem 77 2005 1566 1571 (Pubitemid 40396247)
33. E. Norrby Prions and protein-folding diseases J Intern Med 270 2011 1 14
34. Y.B. Lim, C.E. Mays, Y. Kim, W.B. Titlow, and C. Ryou The inhibition of prions through blocking prion conversion by permanently charged branched polyamines of low cytotoxicity Biomaterials 31 2010 2025 2033
35. H.N. Ai Tran, F. Sousa, and F. Moda A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated Au nanoparticles Nanoscale 2 2010 2724 2732
36. F. Sousa, S. Mandal, and C. Garrovo Functionalized Au nanoparticles: a detailed in vivo multimodal microscopic brain distribution study Nanoscale 2 2010 2826 2834
37. S.J. Xiao, P.P. Hu, and X.D. Wu Sensitive discrimination and detection of prion disease-associated isoform with a dual-aptamer strategy by developing a sandwich structure of magnetic microparticles and quantum dots Anal Chem 82 2010 9736 9742
38. M. Xie, K. Luo, and B.H. Huang PEG-interspersed nitrilotriacetic acid-functionalized quantum dots for site-specific labeling of prion proteins expressed on cell surfaces Biomaterials 31 2010 8362 8370
39. M.C. Kiernan, S. Vucic, and B.C. Cheah Amyotrophic lateral sclerosis Lancet 377 2011 942 955
40. M.L. Bondì, E.F. Craparo, G. Giammona, and F. Drago Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution Nanomedicine-UK 5 2010 25 32
41. D. Bataveljić, S. Stamenković, G. Bačić, and P.R. Andjus Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis Acta Physiol Hung 98 2011 27 31
42. L. Machtoub, D. Bataveljić, and P.R. Andjus Molecular imaging of brain lipid environment of lymphocytes in amyotrophic lateral sclerosis using magnetic resonance imaging and SECARS microscopy Physiol Res 60 Suppl. 1 2011 S121 S127
43. Cho Y, Borgens RB. Polymer and nano-technology applications for repair and reconstruction of the central nervous system. Exp Neurol, 2011, in press.
44. S.S. Ali, J.I. Hardt, and K.L. Quick A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties Free Radic Biol Med 37 2004 1191 1202 (Pubitemid 39296744)
45. M. Das, S. Patil, and N. Bhargava Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons Biomaterials 28 2007 1918 1925 (Pubitemid 46123536)
46. G.Z. Jin, M. Kim, U.S. Shin, and H.W. Kim Neurite outgrowth of dorsal root ganglia neurons is enhanced on aligned nanofibrous biopolymer scaffold with carbon nanotube coating Neurosci Lett 501 2011 10 14
47. J.J. Liu, C.Y. Wang, J.G. Wang, H.J. Ruan, and C.Y. Fan Peripheral nerve regeneration using composite poly(lactic acid-caprolactone)/nerve growth factor conduits prepared by coaxial electrospinning J Biomed Mater Res A 96 2011 13 20
48. M.P. Prabhakaran, L. Ghasemi-Mobarakeh, and S. Ramakrishna Electrospun composite nanofibers for tissue regeneration J Nanosci Nanotechnol 11 2011 3039 3057
49. Lee J, Bashur C, Milroy C, Forciniti L, Austein A, Schmidt C. Nerve growth factor-immobilized electrically conducting fibrous scaffolds for potential use in neural engineering applications. IEEE Trans Nanobiosci, 2011, in press.
50. M. Mahmoudi, S. Laurent, M.A. Shokrgozar, and M. Hosseinkhani Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles ACS Nano 5 2011 7263 7276
51. E. Hutter, S. Boridy, and S. Labrecque Microglial response to gold nanoparticles ACS Nano 4 2010 2595 2606
52. J. Wang, P. Sun, Y. Bao, J. Liu, and L. An Cytotoxicity of single-walled carbon nanotubes on PC12 cells Toxicol In Vitro 25 2011 242 250
53. 2 particles exert size and surface coating dependent retention and lesions on the murine brain Toxicol Lett 207 2011 73 81
54. T.T. Win-Shwe, and H. Fujimaki Nanoparticles and neurotoxicity Int J Mol Sci 12 2011 6267 6280